期刊文献+

术中近距离照射犬肝组织的病理学观察 被引量:1

Responses of canine liver tissue to intraoperative brachytherapy
原文传递
导出
摘要 目的 了解高剂量率192 Ir放射源在不同照射剂量、不同观察时间对正常犬肝组织的放射反应 ,为临床开展近距离治疗肝癌提供病理学参考。方法 选用健康的普通犬 6只 ,常规外科程序开腹 ,在肝左叶平行插入两根钢针 ,针间距 1.5cm ,参考点距放射源中轴外 1cm ;照射剂量为 10、2 0和 30Gy ,每种剂量一只犬分别在照射后 2 0和 6 0d活杀 ,并从照射中心始向外 1,2 ,3和 4cm依次取材 ,观察组织学改变 ;自身肝组织作对比。结果 大体检查 :除照射后 6 0d、照射 10Gy一只犬外 ,所有犬在照射中心均可见坏死灶 ;显微镜下 :照射后 2 0d的病理主要改变是急性坏死和炎性反应 ;在照射后 6 0d、照射 2 0Gy以上 ,出现肝细胞损伤和纤维组织增生明显。 结论 临床近距离放疗肝癌时 ,单次量最好在 10Gy以下 ,照射 2~ 3次 ,总量在 30Gy以下为宜 ;对肿瘤周边欠缺的剂量给予体外照射。 Objective To investigate responses of normal liver tissue to high-dose-rate 192Ir source at different irradiation doses and time phases to provide pathological reference for brachytherapy of liver cancer in clinical practice. Methods Six dogs received routine surgical procedure. Two steel needles were implanted in parallel into the left lobe. The length was 1.5 cm and reference distance 1 cm apart from the source. The irradiation doses were 10, 20 and 30 Gy, respectively. The dogs were killed 20 and 60 days later. The samples of liver tissue were extracted outward from the center for 1, 2 and 3 cm in order. The right lobe was used as the control. Results There was necrosis in the irradiation center in all dogs but one receiving 10 Gy irradiation for 60 days. Microscopic examination showed that the major tissue changes were acute necrosis and inflammatory responses in 20 days. Liver cell damage and fiber tissue proliferation were found in 60 days when the irradiation dose >20 Gy. Conclusions When the irradiation dose is over 20 Gy, severe necrosis of liver tissue appears. Therefore, it is suitable that the irradiation dose is less tan 10 Gy and given for 2-3 fractions during brachytherapy of liver cancer. Meanwhile, the total dose should be less than 30 Gy.
出处 《中华肝胆外科杂志》 CAS CSCD 2003年第6期369-371,共3页 Chinese Journal of Hepatobiliary Surgery
  • 相关文献

参考文献8

  • 1彭开桂,韩福生,刘辉,宋明珠.对不能切除的原发性肝癌综合治疗的临床研究[J].中华放射肿瘤学杂志,2000,9(1):11-13. 被引量:11
  • 2冷祝强,梁赵玉,石珊,胡自省.肝癌介入治疗放射治疗及综合治疗的疗效分析[J].中华放射肿瘤学杂志,2000,9(2):99-101. 被引量:46
  • 3马佰 见:徐燮渊 俞受程 曾逖闻 主编.原发性肝癌[A].见:徐燮渊,俞受程,曾逖闻,主编.肿瘤综合治疗学--新理论新观点新技术:第1版[C].北京:人民军医出版社,2001.382—384.
  • 4徐池 见:申文江 王绿化 主编.肝脏的放射损伤[A].见:申文江,王绿化,主编.放射治疗损伤:第1版[C].北京:中国医药科技出版社,2001.128—133.
  • 5李立,严律南,陈晓理,卢武胜,谢晓东,宫泳松.放射性微球治疗晚期肝癌内照射剂量与疗效关系的探讨[J].中华放射肿瘤学杂志,1998,7(2):105-108. 被引量:3
  • 6Wollner I, Knutsen C, Smith P, et al. Effects of hepatic arterial Yttrium-90 glass microspheres in dogs. Cancer, 1998, 61: 1336-1344,.
  • 7Lau WY, Ho S, Leung TW, et ak Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90 Yttrium microspheres. Int J Radiat Oncol Biol Phys, 1998,40: 583-592.
  • 8Hafeli UO, Casillas S, Dietz DW, et al. Hepatic tumor radioembolization in a rat model using radioactive Rhenium(186Re/188Re)glass microspheres. Int J Radiat Oncol Biol Phys, 1999,44:189-199.

二级参考文献16

  • 1罗鹏飞,胡景钤.经肝动脉途径治疗肝癌的效果分析[J].中华医学杂志,1993,73(3):158-160. 被引量:28
  • 2冯勇,杨秉辉.原发性肝癌的去血供治疗[J].肿瘤,1996,16(1):54-55. 被引量:15
  • 3徐白萱,田嘉禾,张锦明,董宝玮,梁平,龙丽娟,苏莉,王向东.超声引导瘤内注射^(90)Y-GTMS治疗肝恶性肿瘤的研究[J].中华核医学杂志,1996,16(2):103-105. 被引量:8
  • 4陈晓理,吴言涛,严律南,李林,谭天秩,孙文豪,李茂良,贾乾斌,杜景平,沈文律.^(32)磷玻璃微球治疗肝癌的实验研究[J].普外基础与临床杂志,1996,3(2):68-70. 被引量:7
  • 5彭开桂,中华放射肿瘤学杂志,1993年,2卷,3期,144页
  • 6汤钊猷,原发性肝癌的研究与进展,1990年
  • 7Williamson DH,Mellanby T,Methods of enzymaic analysis.New York:Academic Press,1974,1836-1843.
  • 8Yan ZP,Lin G,Zha HY,et al.A experiment study and clinical pilot trial on yttrium 90 glass microspheres through the hepatic artery for treatment of primary liver cancer,1992,72:3210-3215.
  • 9Shepherd FA,Ratstein LE,Houle S,et al.A phase I dose escalation trial of yttrium 90 microspheres in the treatment of primary hepatocellular carcinoma.Cancer,1992,70:2250-2256.
  • 10小林尚志.131 I—LiptodoL肝动脉超选择栓塞加内照射治疗肝细胞癌量效关系的研究[J].日本癌治疗学会志,1989,1:133-141.

共引文献57

同被引文献12

  • 1卢鸣剑,张福君,张亮,吴沛宏,黄金华,范卫君,李传行,李奎,刘健,吴月霞.放射性粒子^(125)I对兔股动脉放射性损伤的实验研究[J].中国微创外科杂志,2007,7(2):134-135. 被引量:10
  • 2杨秀军,马旺扣,肖湘生.组织间植入^(125)I粒子对犬血管影响的组织病理与影像学对照研究[J].中国介入影像与治疗学,2007,4(1):66-70. 被引量:12
  • 3梅雀林,刘鹏程,杨建勇,杜端明,陈在中.^(125)I粒子植入在肝组织应用中的实验评估[J].南方医科大学学报,2007,27(5):675-678. 被引量:7
  • 4Williamson JF. Brachytherapy technology and physics practice since 1950 : a half-century of progress [J ]. Phys Med Biol, 2006, 51 : R303 - 325.
  • 5Nath R, Anderson LL brachytherapy sources Luxton G, et al. Dosimetry of interstitial Therapy Committee Task Physicists in Medicine[J] recommendations of AAPM Radiation Group No.43 American Association of Med Phys, 1995, 22:209 - 234.
  • 6Rivard MJ, Coursey BM, Dewerd LA, et al. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachy- therapy dose calculations[J]. Med Phys, 2004, 31 : 633 - 674.
  • 7Patterson DM, Rustin GJ. Vascular damaging agents [J]. Clin Oncol(R Coil Radiol), 2007, 19:443 - 456.
  • 8Sindelar WF, Kinsella TJ. Normal tissue tolerance to intraoperative radiotherapy[J]. Surg Oncol Clin N Am, 2003, 12:925 - 942.
  • 9Jain D, Wegscheider K, Hartmann F, et al. Differential outcome after intracoronary radiation therapy is related to a simple classification based on lesion length and reference diameter[J]. J Invasive Cardiol, 2005, 17: 256- 261.
  • 10Macchia G, Costamagna G, Morganti AG, et al. Intraluminal brachytherapy without stenting in intrahepatic papillary cholan- giocarcinoma: a case report[J]. Dig Liver Dis, 2005, 37:615 - 618.

引证文献1

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部